Skip to main content
. 2020 Jan 31;34:124–135. doi: 10.1016/j.molmet.2020.01.016

Table 2.

Characteristics of the serum samples before and after processing.

Serum samplesa Original sample
Sample after processingb
Batch Subsequent analysisc
Protein concentration (mg/mL) Protein amount (mg/115 μL) Retained volume (μL) Retained protein
mg (%)
Human HS 2b 54.41 6.26 70 1.02 16.2 2
Human HS 4a 58.80 6.76 80 1.12 16,6 3
Human HS 4b 53.99 6.21 90 1.21 19.5 3
Human HS 5a 65.51 7.53 75 1.74 23.1 3
Human HS 5b 62.54 7.19 100 1.20 16.6 3
Human HS 6b 51.94 5.97 75 1.73 29.0 1
Human HS 6b (technical replicate) 105 1.23 20.6 1 MS (PRM)
Human HS 7b 56.19 6.46 95 1.23 19.1 1 MS (PRM)
Human HS 7b (technical replicate) 75 1.79 27.7 1 MS (PRM)
Human HS 7c 54.92 6.32 70 1.02 16.1 2 MS (DDA)
Rat 45.89 5.28 50 2.04 38.7 3 MS (DDA)
Rat (technical replicate) 70 2.28 43.2 1 MS (PRM)
Horse 54.71 6.29 100 1.34 21.3 3
a

See Supplemental Table S1 for detailed sample data.

b

Removal of albumin and IgG with ProteoExtract (Calbiochem); concentration of proteins with Amicon Ultra 0.5 Centrifugal Filter Devices (Merck).

c

MS: mass spectrometry; PRM: parallel reaction monitoring; DDA: data dependent acquisition.